REFLECTION: Early Cancer Detection
Official Title: REFLECTION: Real World Evidence for Learnings in Early Cancer Detection, a Clinical Learning Program for Galleri.
Sponsor: GRAIL, Inc.
Principle Investigator: Lynn Keenan, MD
Study Description: This study is now closed to new participants. The Reflection study enrolled over 940 Veterans who opted to be screened with Galleri, a multi-cancer early detection blood test, which can detect the presence of 50+ cancers at time of blood draw. Participants will be followed for one year to evaluate cancer status and complete a one-year follow up questionnaire.
The purpose of this study is to understand the real-world experience of Galleri in clinical settings.
Learn More: https://clinicaltrials.gov/study/NCT05205967